KCT0005496已完成未知
Therapeutic Implication of Galectin-3 in Patients with Atrial Fibrillation
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 20(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •1) Admission for catheter ablation of atrial fibrillation
- •2) Cardiac magnetic resonance imaging with gadolinium before ablation
- •3) No history of vascular or malignancy disease affecting the level of serum galectin-3
排除标准
- •1) refuse enrollment
研究者
相似试验
尚未招募
不适用
Galectin-3 and oral submucous fibrosisCTRI/2020/12/029928Dr Hetvi Sheth
已完成
不适用
Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patientson-small cell lung cancerJPRN-UMIN000026869Shiga University of Medical Science250
进行中（未招募）
不适用
se of galectin-3 as a blood marker for patients with Chagas disease.Chronic Chagas Disease with cardiac involvementB57.2RBR-5m6748Hospital São Rafael
招募中
不适用
Prognostic Value of Plasma Galectin-3 Concentrations for Cardiovascular Events in Patients with Heart Failure with Normal Left Ventricular Ejection FractioHeart failure with normal left ventricular ejection fractionJPRN-UMIN000014811Kumamoto University Graduate School of Medical Sciences500
Unknown
3 期
Blocking Extracellular Galectin-3 in Patients With OsteoarthritisOsteoarthritisNCT02800629Massachusetts General Hospital50